Home › Esophageal Adenocarcinoma › Indiana › Gary
Esophageal Adenocarcinoma clinical trials in Gary, IN
3 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Gary (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RecruitingPhase 2/3
- Northwest Cancer Center - Hobart, Hobart · 6 mi away
- Saint Mary Medical Center, Hobart · 6 mi away
- Northwest Cancer Center - Crown Point, Crown Point · 12 mi away
- and 1 more
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RecruitingPhase 3
- Northwest Cancer Center - Hobart, Hobart · 6 mi away
- Saint Mary Medical Center, Hobart · 6 mi away
- Northwest Cancer Center - Crown Point, Crown Point · 12 mi away
- and 2 more
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- UChicago Medicine - Northwest Indiana, Crown Point · 12 mi away
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Arlington, VA11 studies
- Nashville, TN11 studies
- Durham, NC10 studies
- Rochester, MN9 studies
- St. Louis, MO9 studies
- Baldwin Park, CA9 studies
- Jacksonville, FL9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
Other studies in Gary
- Lung Cancer5 studies
- Heart Failure4 studies
- Acute Myeloid Leukemia4 studies
- Ovarian Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Obesity3 studies
- Overweight3 studies
- Breast Cancer3 studies
- Endometrial Cancer3 studies
- Bladder Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Atrial Fibrillation3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.